MARLBOROUGH, Mass.--(BUSINESS WIRE)--#JPMorganconference--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 39th Annual J.P. Morgan...
ALSIP, IL / ACCESSWIRE / December 28, 2020 / Capstone Therapeutics (OTCQB:CAPS) ("the Company"): EXERCISE OF SECURED DEBT AND INTEREST...
KATY, TX / ACCESSWIRE / December 28, 2020 / Neutra Corp. (OTC PINK:NTRR) retail subsidiary VIVIS is launching its Hemp...
Key Capital Invites Partnering Inquiries for COVID-19 Therapeutic Vaccine NEW YORK, NY / ACCESSWIRE / December 28, 2020 / KEY...
First Safety Study Utilizing Ultraviolet A Light Catheter as a Prospective Anti-Infective in Critically Ill, Intubated SARS-Cov-2 Patients ENGLEWOOD, CO...
ROCKVILLE, MD / ACCESSWIRE / December 28, 2020 / The following statement may be attributed to LaVarne A. Burton, president...
NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
2020 Marks Highest Revenue Year in Company History, Customers Surpass Shipment Milestone of 50 Million RF FiltersAUSTIN, Texas, Dec. 28,...
HORSHAM, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical...
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in...
NEW YORK, NY, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “The Company”), a leading biosciences...
--Received Gross Proceeds of $110 Million from Previously Announced PIPE Financing----Executed Additional PIPE Financing of $15 Million-- EMERYVILLE, Calif., Dec....
The trial failed to meet its primary endpoint of complete remission (CR) rateCR rate was 53% higher in eprenetapopt with...
SAN CARLOS, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel...
NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQB: BTTR) (“Better Choice”), an animal health and wellness...
First NDA submission for Company’s lead program, KORSUVA™ Injection –NDA submission includes request for Priority Review under Breakthrough Therapy Designation...
Introductory exhibits at Royal College of Physicians of Thailand and Thailand Cardiologist Annual Conference result in dozens of product trials...
Conference Call and Webcast Today at 4:30 p.m. ETNEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp....
Myovant and Pfizer to jointly develop and commercialize ORGOVYX™ (relugolix) and relugolix combination tablet and share profits and expenses in the...
On-schedule completion of enrollment despite COVID-19 pandemic; unique trial design evaluates safety and efficacy of single & repeat dosesSOUTH SAN...